BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27441081)

  • 1. Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle.
    Roy P; Rau F; Ochala J; Messéant J; Fraysse B; Lainé J; Agbulut O; Butler-Browne G; Furling D; Ferry A
    Skelet Muscle; 2016; 6():23. PubMed ID: 27441081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.
    Goyenvalle A; Vulin A; Fougerousse F; Leturcq F; Kaplan JC; Garcia L; Danos O
    Science; 2004 Dec; 306(5702):1796-9. PubMed ID: 15528407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model.
    Rodino-Klapac LR; Janssen PM; Shontz KM; Canan B; Montgomery CL; Griffin D; Heller K; Schmelzer L; Handy C; Clark KR; Sahenk Z; Mendell JR; Kaspar BK
    Hum Mol Genet; 2013 Dec; 22(24):4929-37. PubMed ID: 23863459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of AAV-U7-induced dystrophin exon skipping and soluble activin Type IIB receptor in mdx mice.
    Hoogaars WM; Mouisel E; Pasternack A; Hulmi JJ; Relizani K; Schuelke M; Schirwis E; Garcia L; Ritvos O; Ferry A; 't Hoen PA; Amthor H
    Hum Gene Ther; 2012 Dec; 23(12):1269-79. PubMed ID: 22894762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy.
    Zhang Y; Yue Y; Li L; Hakim CH; Zhang K; Thomas GD; Duan D
    Hum Mol Genet; 2013 Sep; 22(18):3720-9. PubMed ID: 23681067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
    Trajanovska S; Ban J; Huang J; Gregorevic P; Morsch M; Allen DG; Phillips WD
    J Physiol; 2019 Sep; 597(18):4831-4850. PubMed ID: 31340406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
    El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
    Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.
    Blaauw B; Mammucari C; Toniolo L; Agatea L; Abraham R; Sandri M; Reggiani C; Schiaffino S
    Hum Mol Genet; 2008 Dec; 17(23):3686-96. PubMed ID: 18753145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.
    Lindsay A; Larson AA; Verma M; Ervasti JM; Lowe DA
    J Appl Physiol (1985); 2019 Feb; 126(2):363-375. PubMed ID: 30571283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice.
    Strimpakos G; Corbi N; Pisani C; Di Certo MG; Onori A; Luvisetto S; Severini C; Gabanella F; Monaco L; Mattei E; Passananti C
    J Cell Physiol; 2014 Sep; 229(9):1283-91. PubMed ID: 24469912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic mice.
    Heller KN; Montgomery CL; Janssen PM; Clark KR; Mendell JR; Rodino-Klapac LR
    Mol Ther; 2013 Mar; 21(3):520-5. PubMed ID: 23319059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice.
    Koo T; Malerba A; Athanasopoulos T; Trollet C; Boldrin L; Ferry A; Popplewell L; Foster H; Foster K; Dickson G
    Hum Gene Ther; 2011 Nov; 22(11):1379-88. PubMed ID: 21453126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beneficial effect of chronic muscular exercise on muscle fragility is increased by Prox1 gene transfer in dystrophic mdx muscle.
    Monceau A; Delacroix C; Lemaitre M; Revet G; Furling D; Agbulut O; Klein A; Ferry A
    PLoS One; 2022; 17(4):e0254274. PubMed ID: 35436319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
    Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S
    Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice.
    Watchko J; O'Day T; Wang B; Zhou L; Tang Y; Li J; Xiao X
    Hum Gene Ther; 2002 Aug; 13(12):1451-60. PubMed ID: 12215266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
    Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
    Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of proteases in excitation-contraction coupling failure in muscular dystrophy.
    Mázala DA; Grange RW; Chin ER
    Am J Physiol Cell Physiol; 2015 Jan; 308(1):C33-40. PubMed ID: 25298424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy.
    Le Hir M; Goyenvalle A; Peccate C; Précigout G; Davies KE; Voit T; Garcia L; Lorain S
    Mol Ther; 2013 Aug; 21(8):1551-8. PubMed ID: 23752313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double-knockout mice.
    Yue Y; Liu M; Duan D
    Mol Ther; 2006 Jul; 14(1):79-87. PubMed ID: 16563874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.